Surge

Optimizing surgery with personalized immune insights.

Edited:

📋 Overview of Surge

Founding Year

2021

Estimated Funding

$0000

Size

$0000

Locations

Paris

Primary Industry

Biotechnology, Industry

📙 About Surge

SurgeCare AI offers immune system profiling, which seeks to change how surgery is conducted. It utilizes artificial intelligence (AI), to predict surgical complications, thus improving pre-operative strategies. A machine learning algorithm studies the immune response from one pre-surgical blood sample, which simulates surgical stress and predicts postoperative outcomes accurately.

💰 Recent Investors of Surge

50 Partners, Boutique Venture Partners, Investor

© 2025 Bot Memo. All Rights Reserved.

Subscribe to Bot Memo

As as subscriber, you can explore more AI startups. You also get exclusive AI market gap reports every fortnight in your inbox.*

Continue with Google *We hate spam as much as you do.